LENZ Therapeutics Inc.
LENZ | NASDAQ
$4.08
+$0.01 (+0.25%)
At close: Sep 21, 2026, 4:00 PM ET
$4.08
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $127.61M
Enterprise Value $-91.96M
Beta 1.63
Average Volume 854.64K
Shares Outstanding (Diluted) 31.37M
Shares Change YoY 11.74%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US52635N1037
Price Performance
Price Change 1M -12.4%
Price Change 3M -29.0%
Price Change 6M -55.0%
Price Change YTD -74.5%
Price Change 1Y -90.1%
Price Change 3Y -74.8%
Price Change 5Y -74.8%
1M CAGR (ann.) -22.0%
1Y CAGR (ann.) -90.4%
5Y CAGR (ann.) -31.9%
All-Time CAGR -29.6%
Valuation
PE Ratio -1.00
Forward PE N/A
PEG Ratio 0.02
Forward PEG 0.03
PS Ratio 5.96
Forward PS 3.00
PB Ratio 0.58
P/FCF Ratio -1.12
P/Adj. FCF Ratio -1.01
P/OCF Ratio -1.12
EV/Sales -4.28
EV/EBIT 0.73
EV/EBITDA 0.73
EV/FCF 0.80
Earnings Yield -100.3%
FCF Yield -89.4%
Adj. FCF Yield -98.5%
Financial Health
Net Cash $220M
Total Debt $122K
Cash & Short-Term Investments $220M
Total Assets $236.6M
Current Ratio 13.55
Quick Ratio 13.31
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt -933.67
Interest Coverage 0.00
Altman Z-Score 2.07
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 90.1%
Operating Profit Margin -631.7%
EBITDA Margin -584.6%
Net Profit Margin -586.7%
FCF Margin -532.8%
Adj. FCF Margin -586.9%
SBC / Revenue 54.1%
SBC Impact (per share) -10.2%
Returns
Return on Assets -53.3%
Return on Equity -53.4%
Return on Invested Capital -61.8%
Return on Capital Employed -61.8%
Return on Tangible Assets -53.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 121.7%
Revenue CAGR 5Y 90.6%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 52.1%
EPS CAGR 5Y 32.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y -25.7%
FCF CAGR 5Y -8.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y 30.4%
Revenue Growth Next 3Y 89.3%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$1.02
EPS Growth Est (next Q) 72.9%
Revenue Est (next Q) $4.49M
Revenue Growth Est (next Q) -64.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $7
Price Target Upside 71.6%
Cash Flow
Operating Cash Flow $-113.91M
Free Cash Flow $-114.42M
Adj. Free Cash Flow $-126.04M
FCF Per Share -$3.65
OCF Per Share -$3.63
OCF/S Ratio -530.4%
Income Statement
Revenue $21.48M
Gross Profit $19.36M
Operating Income $-135.66M
EBITDA $-125.54M
Net Income $-126M
EPS (Diluted) -$4.09
Revenue / Employee $141.28K
Profit / Employee $-828.96K
Employees 152
Add to Watchlist
Select watchlists to add or remove LENZ